February 9, 2010
Current Hepatitis ReportsCurrent Hepatitis Reports
Current Hepatitis ReportsCurrent Hepatitis Reports
Roche
Last Five Articles Visited

Future Therapies for Hepatitis C

Treatment of Nonresponders toStandard Hepatitis C Therapy

Fibrosis Markers in Hepatitis C

Treatment of HCV Infection in Patients with Renal Failure

Web Alert - Volume: 06, Issue: 2
Contact Us
Current Science, Inc.
400 Market Street
Suite 700
Philadelphia, PA 19106
Tel: 1-800-427-1796 (U.S.)
(215) 574-2266
Fax: (215) 574-2225
Volume 5, Issue 3: August 2006
Web Alert
This alert contains detailed reviews of Web sites concerning hepatitis.
Full Text • PDF • pp. 75-76
Hepatitis C: Current and Future Therapies
Ira M. Jacobson, section editor
1. The Impact of Race and Ethnicity on the Treatment of Hepatitis C Disease
Carla W. Brady and Andrew J. Muir
Abstract • Full Text • PDF • pp. 79-85
2. Fibrosis Markers in Hepatitis C
Carla W. Brady, John G. McHutchison, and Keyur Patel
Abstract • Full Text • PDF • pp. 86-93
3. Antifibrotic Targets and Therapyin HCV
Efsevia Albanis and Scott L. Friedman
Abstract • Full Text • PDF • pp. 94-100
4. Treatment of HCV Infection in Patients with Renal Failure
Suphamai Bunnapradist, Fabrizio Fabrizi, and Paul Martin
Abstract • Full Text • PDF • pp. 101-107
5. Treatment of Nonresponders toStandard Hepatitis C Therapy
Maya Gambarin-Gelwan and Ira M. Jacobson
Abstract • Full Text • PDF • pp. 108-113
6. Chronic Hepatitis C:Treatment of Pegylated Interferon/Ribavirin Nonresponders
Abstract • Full Text • PDF • p. 114
7. Future Therapies for Hepatitis C
Asim S. Khokhar, Valerie Byrnes, and Nezam H. Afdhal
Abstract • Full Text • PDF • pp. 121-128
© 2010 Current Science, Inc. All rights reserved. Contact us at: info@hepatitisreports.com.
Current Hepatitis Reports: 1540-3416 (print ISSN), 1541-0706 (Web ISSN)